Sio Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-42,379
| Closed | -$3.94M | – | 85 |
|
|
2021
Q4 | $3.94M | Buy |
42,379
+20,641
| +95% | +$1.36M | 1.19% | 23 |
|
|
2021
Q3 | $1.29M | Hold |
21,738
| – | – | 0.41% | 50 |
|
|
2021
Q2 | $1.48M | Hold |
21,738
| – | – | 0.37% | 60 |
|
|
2021
Q1 | $1.51M | Sell |
21,738
-36,000
| -62% | -$2.77M | 0.31% | 71 |
|
|
2020
Q4 | $4.44M | Sell |
57,738
-14,015
| -20% | -$1.05M | 0.91% | 36 |
|
|
2020
Q3 | $5.37M | Sell |
71,753
-23,400
| -25% | -$1.56M | 1.06% | 33 |
|
|
2020
Q2 | $5.99M | Buy |
95,153
+10,000
| +12% | +$550K | 1.75% | 22 |
|
|
2020
Q1 | $3.58M | Sell |
85,153
-4,204
| -5% | -$193K | 1.2% | 25 |
|
|
2019
Q4 | $4.06M | Buy |
89,357
+45,500
| +104% | +$2.15M | 0.97% | 29 |
|
|
2019
Q3 | $2.01M | Buy |
+43,857
| New | +$2.47M | 0.65% | 43 |
|
|
2017
Q4 | – | Sell |
-72,086
| Closed | -$1.84M | – | 74 |
|
|
2017
Q3 | $1.84M | Buy |
72,086
+2,734
| +4% | +$62.7K | 0.95% | 35 |
|
|
2017
Q2 | $1.17M | Buy |
+69,352
| New | +$951K | 0.56% | 47 |
|
Sio Capital Management's ARNA Position: Q1 2022 in Review
Sio Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 42,379 shares — an estimated $3.94M sold.
Sio Capital Management first reported a position in ARNA in Q2 2017 and held it in 12 quarters. The position peaked at $5.99M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Sio Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Sio Capital Management sold 42,379 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.94M.
- Sio Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 12 quarters.
- Sio Capital Management's Arena Pharmaceuticals Inc position peaked at $5.99M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Sio Capital Management's 13F filing for Q1 2022, filed 16 May 2022.